Next Article in Journal
The Epidemiology, Management and Therapeutic Outcomes of Subdural Empyema in Neonates with Acute Bacterial Meningitis
Previous Article in Journal
Antimicrobial De-Escalation in Critically Ill Patients
Previous Article in Special Issue
Coagulase-Negative Staphylococci as an Etiologic Agent of Ovine Mastitis, with a Focus on Subclinical Forms
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 13
Issue 4
10.3390/antibiotics13040376
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Rabbits as a Reservoir of Multidrug-Resistant Escherichia coli: Clonal Lineages and Public Health Impact

by
Adriana Silva
1,2,3,4,
Vanessa Silva
1,2,3,4,
Teresa Tavares
1,2,3,4,5,
María López
6,
Beatriz Rojo-Bezares
6,
José Eduardo Pereira
7,8,
Virgílio Falco
9,10,
Patrícia Valentão
10,11,
Gilberto Igrejas
2,3,4,
Yolanda Sáenz
6 and
Patrícia Poeta
1,2,7,8,*
1
Microbiology and Antibiotic Resistance Team (MicroART), Department of Veterinary Sciences, University of Traás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
2
LAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
3
Department of Genetics and Biotechnology, University of Traás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
4
Functional Genomics and Proteomics Unit, University of Traás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
5
José Azevedo Monteiro, Lda., Rua do Campo Grande 309, 4625-679 Vila Boa do Bispo, Portugal
6
Área de Microbiología Molecular, Centro de Investigación Biomédica de La Rioja (CIBIR), 26006 Logroño, Spain
7
CECAV—Veterinary and Animal Research Centre, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal
8
Associate Laboratory for Animal and Veterinary Sciences (AL4AnimalS), 5000-801 Vila Real, Portugal
9
Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Universidade de Trás-os-Montes e Alto Douro (UTAD), 5000-801 Vila Real, Portugal
10
Laboratory for Green Chemistry (LAQV) of the Network of Chemistry and Technology (REQUIMTE), Universidade do Porto (UP), 2829-516 Caparica, Portugal
11
REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, 4050-313 Porto, Portugal
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
Antibiotics 2024, 13(4), 376; https://doi.org/10.3390/antibiotics13040376
Submission received: 10 March 2024 / Revised: 12 April 2024 / Accepted: 18 April 2024 / Published: 20 April 2024
(This article belongs to the Special Issue Zoonotic Diseases: Pathogen Detection and Antimicrobial Treatment)
Browse Figures
Versions Notes

Abstract

:
Escherichia coli, including extended-spectrum β-lactamases (ESBL)-producing strains, poses a global health threat due to multidrug resistance, compromising food safety and environmental integrity. In industrial settings, rabbits raised for meat have the highest consumption of antimicrobial agents compared to other food-producing animals. The European Union is facing challenges in rabbit farming as rabbit consumption declines and antibiotic-resistant strains of E. coli cause enteric diseases. The aim of this study was to investigate the antibiotic resistance profile, genetic diversity, and biofilm formation in cefotaxime-resistant E. coli strains isolated from twenty rabbit farms in Northern Portugal to address the effect of the pressing issue of antibiotic resistance in the rabbit farming industry. Resistance to critically antibiotics was observed, with high levels of resistance to several categories, such as tetracycline, ampicillin, aztreonam, and streptomycin. However, all isolates were susceptible to cefoxitin and imipenem. Multidrug resistance was common, with strains showing resistance to all antibiotics tested. The blaCTX-M variants (blaCTX-3G and blaCTX-M9), followed by the tetracycline resistance genes, were the most frequent resistance genes found. ST10 clones exhibiting significant resistance to various categories of antibiotics and harboring different resistance genes were detected. ST457 and ST2325 were important sequence types due to their association with ESBL-E. coli isolates and have been widely distributed in a variety of environments and host species. The strains evaluated showed a high capacity for biofilm formation, which varied when they were grouped by the number of classes of antibiotics to which they showed resistance (i.e., seven different classes of antibiotics, six classes of antibiotics, and three/four/five classes of antibiotics). The One Health approach integrates efforts to combat antimicrobial resistance in rabbit farming through interdisciplinary collaboration of human, animal, and environmental health. Our findings are worrisome and raise concerns. The extensive usage of antibiotics in rabbit farming emphasizes the urgent need to establish active surveillance systems.

1. Introduction

Escherichia coli poses a serious threat to human and animal health and compromises food safety [1]. The emergence of multidrug resistance (MDR) has aggravated the situation with the emergence and dissemination of strains harboring extended-spectrum β-lactamases (ESBL) [2,3]. These β-lactamases contribute to antimicrobial multidrug resistance, since the strains that express these enzymes often show simultaneous resistance to other classes of antibiotics. In addition, the continuous mutations in the genes that encode β-lactamases, which are a direct response to the overuse of antibiotics, broaden their spectrum of action [4,5], and their continued mutation is a direct response to the overuse of antibiotics [6]. The global distribution of ESBLs and MDR E. coli represents a growing issue that extends beyond medical/healthcare systems and impacts food safety and environmental contamination [5]. ESBL-producing bacteria can be transmitted among humans and animals through the food chain and the environment [4].
Frequent use of antibiotics in livestock farming has been criticized for promoting antibiotic resistance. Factors that influence antibiotic resistance include farm management, water treatment, fertilizer handling, and wildlife management [2]. Contamination of food with antimicrobial-resistant bacteria occurs due to antibiotic use and through cross-contamination directly intended for human consumption [1,7]. The emergence of antimicrobial resistance poses a serious threat to human and animal health, and the widespread use of antibiotics in food animals has raised global concerns that impact both veterinary and human medicine. Many of the antibiotics used in humans are also being used in animal therapy [8]. Rabbits reared for meat in industrial farms exhibit the highest rates of antimicrobial usage compared to other food-producing animals, leading to alarming rates of antimicrobial resistance within the industry [9].
The European Union is the second largest producer of meat rabbits in the world, after China. The Union dominates global imports and exports, accounting for 93% of the market share, with Germany, Belgium, and Portugal being the main importers. Together, these countries contribute 14% of the rabbit meat in Europe; however, over the past two decades, the number of commercial rabbit farms has decreased across the European Union due to a decline in rabbit meat consumption [10]. E. coli is principally responsible for neonatal and post-weaning colibacillosis in rabbits, which is frequently accompanied by enteritis and diarrhea. The RESAPATH surveillance system produced susceptibility data for E. coli isolates from rabbits in 2020, with the majority coming from digestive pathology cases in 2018. Of the 277 isolates examined, 70.8% were associated with digestive problems, and treatment frequently included sulfonamides, fluoroquinolones, and aminoglycosides. Sulfonamides-trimethoprim had a greater resistance rate, although fluoroquinolone resistance was rare. Only 1% of isolates were resistant to third-generation cephalosporin [11]. Breeding rabbits is a health-risky industry, often suffering from high economic losses due to enteric diseases caused by E. coli colonization in commercial farms [12].
Antibiotic resistance in rabbits is a pressing issue due to limited research linking clonal E. coli strains to resistance, mainly in Portugal. High levels of resistance have been observed in Italian [13] and Chinese [14] studies, with consistent prevalence of β-lactamase genes like blaTEM and blaCTX-M across studies [7]. Colistin resistance in rabbits is a concern in Portugal [13], as it is potentially transmitted through rabbit husbandry systems and the food chain. Common findings include increased resistance to major antibiotics and specific β-lactamase genes. Common sequence types like ST40 suggest the clonal and zoonotic potential of antibiotic-resistant E. coli strains [7].
Antibiotic resistance in commensal bacteria from food animals is a global concern, with research focusing on the effects of antibiotic use on animals and the potential transmission of resistant bacteria to humans. The use of antibiotics in food-producing animals has led to the development of MDR food bacteria like E. coli. While studies have primarily focused on E. coli’s prevalence in other livestock animals, there is a significant lack of research on rabbits [4]. Rabbit breeding, despite being a niche farm business, can lead to the spread of MDR bacteria, and in Portugal, where rabbit meat consumption is common, there have been no comprehensive studies analyzing a large number of farms to identify any consistent patterns in the results [15]. Therefore, the aim of our study was to investigate the prevalence of Cefotaxime (CTX)-resistant E. coli in healthy rabbits from 20 different intensive farms across northern Portugal, where there is a high concentration of rabbit farms. This work provides the distribution of antibiotic resistance profiles, virulence, genetic diversity, and biofilm formation of CTX-resistant E. coli populations in healthy rabbits from various farms across Portugal and highlights the potential public health implications that affects farmers, food, the environment, and surrounding crops. E. coli poses a significant threat to rabbit meat production and, consequently, food safety.

2. Results

2.1. Bacteria Isolation

From October 2022 to February 2023, a total of 295 fecal samples were received from 20 different rabbit farms. Cefotaxime (CTX)-resistant E. coli isolates were isolated from 48 samples, and these 48 isolates (16.27%) were obtained from 6 rabbit farms (Farm 2, Farm 3, Farm 4, Farm 5, Farm 6, and Farm 13).

2.2. Antibiotic Resistance Phenotypes

The study examined the resistance patterns of various antibiotics in both critically important antimicrobials for the human therapeutic (CIA) and critically important veterinary antibiotics (VCIA) categories. It found ampicillin, amoxicillin-clavulanic acid, amikacin, gentamicin, streptomycin, tobramycin, and ciprofloxacin in both categories; ceftazidime, cefotaxime, aztreonam, and imipenem in CIA categories; and tetracycline in both categories. The 48 CTX-resistant E. coli isolates showed high rates of resistance to critically important antibiotics used in both human and veterinary medicine: ampicillin (100%), aztreonam (97.8%), and streptomycin (93.7%). Among the antibiotics tested, the following resistance rates were found: amoxicillin + clavulanic acid (54.16%), amikacin (8.3%), gentamicin (10.41%), tobramycin (64.58%), ceftazidime (14.58%), nalidixic acid and ciprofloxacin (25%), trimethoprim/sulfamethoxazole (75%), tetracycline (91.6%), and chloramphenicol (72.9%). The broad-spectrum β-lactam antibiotics cefoxitin and imipenem remain effective against all isolates. As Figure 1 shows, all 48 CTX-resistant E. coli isolates exhibited MDR profiles to multiple classes of antibiotics (at least three classes of antimicrobial agents). Eight isolates were resistant to seven different classes of antibiotics, and twenty-seven isolates were resistant to six different classes of antibiotics. Additionally, four isolates exhibited resistance to five classes of antibiotics, and six isolates exhibited resistance to three different classes of antibiotics.

2.3. Molecular Characterization and Multilocus Sequence Typing (MLST)

The ESBL-encoding genes blaCTX-M, blaTEM, blaSHV, and blaOXA were examined in all isolates according to the phenotypic resistance that they possess, and two different blaCTX-M variants were detected among our E. coli strains: blaCTX-3G (72.91%) and blaCTX-M9 (60.41%) (Table 1). The blaTEM was detected in 62.5% of our isolates, blaSHV in 6.25% of isolates, and blaOXA in none of the isolates. Several other resistance genes were also detected in our study, with lower prevalence. These genes included tetA (66.6%) and tetB (33.3%), associated with resistance to tetracycline; and aac(6′)-Ib (18.75%), aac(3)-II (10.41%), and aac(3)-IV (10.41%), associated with aminoglycoside resistance. The qnrA (20.83%) and qnrS (20.83%) genes, both associated with resistance to quinolones, were also identified. The sul3 gene, associated with resistance to sulfonamides, was found in 64.58% of the isolates, sul1 in 35.41%, and sul2 in 29.16% of the CTX-resistant E. coli isolates. The cmlA gene, associated with chloramphenicol resistance, was detected in 43.75% of the isolates. Furthermore, the integrase gene (intI1) was found in 32 isolates, suggesting the presence of class 1 integrons and their involvement in rearrangement of gene cassettes and in the development of antibiotic resistance. Genes associated with virulence factors were widespread, and they were found in all E. coli isolates in this study, including fimA, bfp, aer, cnf1, papC, and papG-II. In Table 1 it is possible to observe the phenotypic and genotypic results of 29 strains of CTX-resistant E. coli that were not subjected to analysis by MLST. In the case of Table 2, we verified the phenotypic and genotypic analysis and sequence types of the 19 CTX-resistant E. coli isolates chosen for the MLST analysis.
Phylogenetic group A was the most prevalent (56.25%), followed by group B1 (37.5%) and group D (2.08%). The 48 isolates analyzed belonged to 10 different pulsotypes (Figure 2). The sequence types (ST) were determined among 19 E. coli strains (at least one strain per PFGE pattern) using the MLST method. Seven different ST were observed: ST10, ST457, ST1611, ST2325, ST2825, ST8470, and ST8823.

2.4. Quantification of Biofilm Formation

A microtiter plate assay was used to measure the biofilm production in all 48 CTX-resistant E. coli strains isolated. All isolates showed biofilm formation. To ensure consistency, the results were normalized against E. coli ATCC 25922. Figure 3 shows the biofilm formation of each isolate grouped by resistance phenotype (seven different classes of antibiotics, six classes of antibiotics and three/four/five classes of antibiotics). Strains belonging to three/four/five classes of antibiotics had a significantly higher average biofilm formation rate (p < 0.001) and showed the highest biofilm production, followed by those belonging to six classes of antibiotics (p < 0.05) and those belonging to seven classes of antibiotics (p < 0.001). The strain with the highest biofilm formation belonged to the group resistant to three/four/five classes of antibiotics, and the strain that produced the least biofilm mass belonged to the group resistant to 7 classes of antibiotics.

3. Discussion

The industrial production of rabbits for meat, despite being limited to a few countries, is unsustainable due to the global threat of antimicrobial resistance, high antibiotic levels, and potential sharing of MDR genotypes between farm workers and rabbits [16]. Oral medication, commonly administered to rabbits, potentially leads to under-dosing of large groups of animals in a herd and contributes to antimicrobial resistance development. Economic factors, particularly the costs associated with antimicrobial treatment, play a significant role, especially in less profitable livestock productions like rabbit meat [17]. Compared to other food-producing animals, rabbits raised for meat in industrial settings are the most abundant consumers of antimicrobial agents [16]. The study of E. coli antimicrobial resistance provides insights into the reservoir of resistant bacteria in healthy animals and their food, potentially facilitating the transfer of resistance between animal populations and humans [18].

3.1. Antibiotic Resistance in Rabbit Farm Environments

In our study, we performed an analysis of rabbit fecal samples, obtaining 15 samples per farm from 20 different rabbit farms located in the Trás-os-Montes, Alto Tâmega, and Minho regions. Among the 20 farms investigated, 48 CTX-resistant E. coli strains were isolated in samples from only six different farms (Farm 2, Farm 3, Farm 4, Farm 5, Farm 6 and Farm 13). None of these farms were related to each other, nor were they located in the same proximity. Additionally, we found that the positive samples (16.27%) exhibiting growth were detected in the Ave and Cávado regions, with no detection of CTX-resistant E. coli strains in the Trás-os-Montes, Alto Tâmega, or Douro regions. The locations where the samples tested positive for E. coli CTX-resistance were in closely populated areas, particularly in the immediate neighborhoods of major cities such as Braga, Barcelos, Vila Nova de Famalicão, and Guimarães. Additionally, three of these farms were located near livestock industries, including cattle and poultry farms. In contrast, all other farms where CTX-resistant E. coli strains were not detected were in remote areas, far from human settlements and residential areas. This represents a compelling example of the One Health approach and underscores the need to be vigilant of this pathogen in order to reduce the potential for zoonotic transmission and disease outbreaks. Several studies [19] have shown that E. coli isolated from rabbits can be considered a potential zoonotic transmission in pet rabbits, farm rabbits, and wild rabbits. Rabbits can serve as reservoirs for antimicrobial resistance genes, potentially spreading them to surrounding ecosystems, and may spread pathogenic bacteria in the environment [19]. Regarding domestic rabbits and pet rabbits, the dissemination of resistant bacteria can occur in different ways. In pet species, the close human–animal interface poses a potential public health risk for the transmission of zoonotic diseases from rabbits to their owners, particularly when good hygiene practices are not followed [20]. In meat rabbits, transmission can occur from rabbit to human and from rabbit to other animal through bacterial transmission (and vice versa) if biosecurity practices are poor. Regardless of farm size, the risk of disease transfer is significantly increased not just between rabbits, but also between rabbits and humans [21]. Regarding the results shown in our study, we found that farms located in urban areas have CTX-resistant E. coli, which could happen due to the zoonotic potential that E. coli has and due to the contamination, that can occur through soil, air, and water. Direct contact with environments contributes to contamination with antibiotic-resistant bacteria [22] The One Health approach emphasizes understanding the connections between human, animal, and environmental microbiota. Transmission of antibiotic resistance genes between livestock and humans can occur through direct and indirect contact. Soil and airborne transmission are also concerns [23].
The study examined seven antibiotics listed as both critically important antimicrobials for human therapeutics (CIA) and critically important veterinary antibiotics (VCIA), including ampicillin, amoxicillin–clavulanic acid, amikacin, gentamicin, streptomycin, tobramycin, and ciprofloxacin. Four were exclusively in the CIA category: ceftazidime, cefotaxime, aztreonam, and imipenem. Additionally, a few antibiotics, such as cefoxitin, chloramphenicol, and -trimethoprim/sulfamethoxazole, were included in the highly important antibiotics (HIA) list by the World Health Organization (WHO). Furthermore, tetracycline was listed in both the HIA and VCIA categories [24]. Our findings reveal alarming levels of resistance to several critically important antibiotics used in both human and veterinary medicine: tetracycline (91.6%), ampicillin (100%), aztreonam (97.8%), streptomycin (93.7%), tobramycin (64.58%), trimethoprim/sulfamethoxazole (75%), amoxicillin–clavulanic acid (54.16%), and chloramphenicol (72.9%). Nevertheless, some broad-spectrum β-lactam antibiotics (cefoxitin and ceftazidime), as well as nalidixic acid, remain effective, with low rates of phenotypic resistance (25%), as well as imipenem, for which no resistance was observed. The β-lactams are rarely used in rabbits due to drug-related diarrhea, leading to E. coli isolates being almost wild-type for CTX [16]. However, in this study, we found that antibiotics belonging to this class of antibiotics have high levels of resistance. Despite chloramphenicol having been banned in food-producing animals for 20 years, nearly one in four E. coli indicators showed reduced susceptibility to this drug, and occurrence has also been reported in other food-producing animals [16].
In our study, high resistance to this antibiotic was reported in our isolates. Limited studies have evaluated antibiotic resistance in domestic rabbits, but existing research suggests higher levels of resistance to tetracycline and ampicillin in other rabbit farms. A study in China [14] found increased levels of resistance to tetracycline and ampicillin (78.2% and 65.5%, respectively). However, our study found even higher levels of resistance compared to the study in China. Another study in Tunisia [12] reported similarly high rates of antibiotic resistance to tetracyclines, with the highest resistance being 95%. However, ampicillin showed the highest resistance rate in our study. High levels of tetracycline resistance have also been reported in rabbit farms worldwide due to the widespread use of tetracyclines for controlling and preventing rabbit diseases. The frequent use in both the veterinary and human health sectors has been cited as a contributing factor to the emergence and spread of tetracycline-resistant bacteria [25]. While our research focused on intensive rabbit farms, similar studies on wild rabbits in Europe have found resistance to E. coli. A study in northern Portugal [26] found that 57.1% of the samples tested positive for E. coli isolates with resistance patterns to antibiotics such as ampicillin, sulfamethoxazole/trimethoprim, and tetracycline. This resistance differs from higher levels reported in food-producing animals. Another study in wild rabbits in Azores [27] found E. coli isolates resistant to common antibiotics, suggesting that wild rabbits act as reservoirs of antimicrobial-resistant genes, similarly to those used for consumption. The presence of MDR strains poses a potential threat to public health, and the use of antibiotics in livestock production leads to the development of MDR and ESBL E. coli strains, making them difficult to treat, as well as a significant reservoir of resistance genes [7,14]. In our study, all E. coli isolates showed MDR, with eight isolates being resistant to seven different antibiotics classes, twenty-seven to six different classes, four to five different classes, and six to three different classes. The detection of MDR strains on all farms highlights a growing concern about rabbits as production animals. MDR pathogens pose a significant threat because they can cause severe and long-lasting infections, raising the possibility of a global pandemic [28]. Studies worldwide consistently show high rates of MDR among E. coli isolates, which often exhibit resistance to various antibiotics, indicating broad-spectrum antimicrobial agents [7]. This study examined antibiotic resistance genes in CTX-resistant E. coli isolates, analyzing β-lactamase genes and non-β-lactams resistance. The study found two groups of blaCTX-M in E. coli, blaCTX-3G (72.91%) and blaCTX-M9 (60.41%), among ESBL-producing E. coli. The emergence of ESBL-producing E. coli in food-producing animals is a major concern due to reduced treatment efficacy and increased morbidity and mortality rates. Studies have confirmed the presence of these bacteria in livestock, highlighting the need for a One Health strategy to combat antibiotic resistance [7]. Tetracycline resistance in E. coli isolates is facilitated by active efflux from tetA and tetB genes [27], which, in our study, had high rates of resistance. Aminoglycoside resistance genes (aac(6)-Ib, aph(3), acc(3)-II, and acc(3)-IV), quinolone resistance genes (qnrA and qnrS), sulfonamide resistance genes (sul2 and sul3), and chloramphenicol resistance genes (cmlA) exhibited a significant prevalence among isolates resistant to the antibiotics for which they provide resistance. blaTEM is a β-lactamase gene and the primary cause of ampicillin resistance in E. coli. It is found in food sources, humans, and healthy animals in Spain [14]. In this study, 62.5% of E. coli isolates carried this gene. Previous studies of rabbit farming have found a similar prevalence of resistance genes to our study, as demonstrated by studies in Italy [13], China [14], and Portugal [29]. These studies reported a significant presence of genes conferring resistance to β-lactams, such as blaTEM and blaCTX, as well as genes related to tetracyclines, sulfonamides, and aminoglycosides. The study conducted in Portugal identified the mcr-1 gene [22]; the presence of this gene was not detected in any E. coli isolates in our study. The rise in antibiotic resistance in E. coli isolates from intensive rabbit farms is consistent with similar trends in other animals used for consumption, such as swine, poultry, and cattle. Factors contributing to this resistance include population growth and increased meat production globally. Although antibiotics were banned for growth promotion in food-producing animals in 2006 to combat resistance and eliminate residues in meat, the industry continues to be a significant contributor to antibiotic resistance. Livestock, particularly poultry, swine, and dairy cattle, account for 50–80% of antibiotic use, resulting in high resistance to antibiotics like tetracyclines, sulfonamides, and penicillins [7]. This research suggests that the high levels of resistance in intensive rabbit farms reflect an overall trend of antibiotic resistance in various food-producing animals worldwide.

3.2. Genetic Diversity of CTX-Resistant E. coli in Rabbit Farms

The study analyzed 48 isolates from 10 different pulsotypes, and some isolates were clonally related. The study found that Farm 2 displayed the P10 cluster and Farm 3 had the highest clonal diversity among the farms, with eight isolates distributed across three distinct clusters (P1, P4, and P9). Farm 4 and Farm 6 each had a single cluster associated, the P8 and P5 clusters, respectively, while Farm 5 had 12 isolates divided into 2 distinct clusters (P2 and P3), and Farm 13 had isolates divided into two distinct clusters (P6 and P7). In all cases, similarities existed only between CTX-resistant E. coli strains isolated within each farm, and not between CTX-resistant E. coli strains from different farms. MLST analysis and clonal lineages were assessed using at least one strain per PFGE pattern. Seven different STs were observed among 19 E. coli strains: ST10, ST457, ST1611, ST2325, ST2825, ST8470, and ST8823. The study found high genetic diversity in six rabbit farms. Farm 2 and Farm 4 had the same clonal lineage, ST10, but the strains belonged to different pulsotypes. For Farm 2, the ST10 clone showed remarkable antibiotic resistance across seven classes and several resistance genes, indicating a significant genetic diversity in these farms. Phylogenetically, it fit into group A and contained virulence-associated genes like fimA and bfp. The other ST10 clone exhibited resistance to six different classes of antibiotics, but unlike the clone belonging to Farm 2, it did not exhibit resistance to the quinolones. Phylogenetically, it fit into group A and contained virulence-associated genes such as papG-III, fimA, and bfp. The identification of MDR E. coli ST10 clones as persistent One Health clones underscores the interconnection between humans, animals, and environmental health and has been documented across multiple hosts and sources, including high-risk pandemic lineages. Infections caused by high-risk strains are frequently resistant to most commercially available antibiotics, including antibiotics used as the last resort. These results emphasize the need for coordinated efforts to mitigate the spread of antimicrobial resistance strains across different sectors [30]. Regarding Farm 3, we selected four strains for analysis and confirmed the presence of two different STs, two strains of ST1611 (P4) and two strains of ST8470 (P9), which phylogenetically belong to B1 and A, respectively. These isolates have very complex resistance profiles: resistance to six and seven different classes of antibiotics, respectively. ST1611 has been reported in several livestock and food product studies in Italy [31], Poland [32], and China [33]. One of the studies involved rabbits in Italy [13]. Regarding ST8470, it is important to highlight that it belongs to clonal complex 10, such as ST10. According to Enterobase, it was detected in 2014 in a sample of humans in Denmark, and there is no further record of this ST in any other environment. This confirms its ubiquitous distribution between different reservoirs and the clonal cross-species transmission of E. coli in livestock animals and humans. On Farm 5, four different isolates were analyzed, all of which detected the ST2825 clonal strain, but the strains belonged to different pulsotypes (P2/P3). Studies conducted in livestock have found no evidence of this clonal lineage. However, this ST was first detected in marine sediments along the Adriatic coast, where MDR E. coli strains were isolated [34]. Regarding the isolates analyzed on Farm 6, we confirmed the presence of clonal lineage ST8823 in the two selected isolates. EnteroBase records demonstrate the presence of this ST in wildlife, environment, and poultry research geographically in Gambia, the United Kingdom, Kenya, the United States, and the United Arab Emirates from 2019 to 2013. Since this ST was detected only in poultry in 2023, we can conclude that this is the case, and since this ST was also found in rabbit breeding, is already widespread in livestock (https://enterobase.warwick.ac.uk (accessed on 6 February 2024)). Farm 13 was the last rabbit farm where CTX-resistant E. coli was isolated, with seven strains analyzed for MLST. Two ST types were detected, ST457 and ST2325, with ST2325 being the most common. The ST457 has been described as an emerging extraintestinal pathogenic E. coli mainly found in wildlife and in food-producing animals [35]. It has a wide host range with global distribution, indicating that ST457 has been reported from different sources in studies on all continents [35]; it is found in marine environments and bloodstream infections, and has been reported in healthy and sick humans, poultry, cattle, swine, wild animals, livestock, companion animals, water, and food [35,36,37]. This E. coli sequence, type ST457, showed a remarkable ability to capture mobile elements that carry and transmit genes encoding resistance to clinically important antibiotics [35]. ST2325 is the most widespread in our study, and has so far been detected in a variety of environments, including livestock [38], stray dogs [39], food products (meat), and the environment (soil) [40]. It is primarily associated with ESBL-E. coli isolates.
The identification of distinct STs, including high-risk and pandemic clones, highlights the potential public health implications of antimicrobial resistance in agricultural settings. It also emphasizes the interconnectedness of human, animal, and environmental health, as evidenced by the widespread distribution of certain STs across multiple reservoirs. The detection of the same STs in different environments and host species demonstrates their ability to adapt and spread widely, posing a significant threat to global health security.

3.3. Biofilm Formation in MDR E. coli Isolated from Rabbit Farms

E. coli biofilm production ability may pose a significant threat to food processing and production, as it increases bacterial resistance to disinfectants, increasing the risk of cross-infection and causing harm to consumer health [41]. In our study, we analyzed the biofilm formation of 48 CTX-resistant E. coli-grouped antibiotic resistance phenotypes. Strains showing resistance to three/four/five different categories had higher average biofilm formation rates and the highest biofilm production, followed by those in the six and seven classes. Several studies have aimed to determine the relationship between MDR profiles and their ability to form biofilms. In our study, all the strains were MDR, and we tried to relate the number of classes they would be resistant to with their ability to form biofilms. The results showed that the number of classes of resistance did not affect biofilm production, since resistance to seven classes was the category that resulted in lower biofilm production when compared to the others. Regarding other studies, there is no information concerning biofilm formation in E. coli strains isolated from rabbit farms. However, our results can be compared with other studies conducted on livestock and food products. A study in China found that 25.39% of E. coli strains from poultry meat formed biofilms, with high-producing strains found in beef [42]. Stronger biofilm-forming strains were also found in poultry isolates [43]. In Bulgaria, isolates from three industrial farms formed strongly adherent biofilms, indicating the presence of E. coli in various meat products [44]. The presence of resistance to commonly used antimicrobials, coupled with the occurrence of MDR strains and strong biofilm formation ability, is alarming. However, in our study, we were unable to verify that the number of antibiotic classes to which the strains are resistant influences biofilm formation. The antimicrobial treatment of biofilms leads the formation of persister cells that can tolerate high levels of antibacterial compounds, which continue to form biofilms even after treatment has finished, transmitting between reservoirs and infecting humans [45].
The rational use of and reduction in antibiotics in rabbit farms is hindered by antibiotic administration laws, economic constraints, a lack of biosafety standards, consumer demand, and inadequate training. The rabbit industry lacks biosecurity measures, leaving rabbits vulnerable to health risks. MDR strains are disseminated and classified as pandemic and high-risk clones, making them more susceptible to infections that could lead to mortality. There is growing demand, but less pressure from consumers, for rabbit meat products to meet specific standards to reduce antibiotic use [9]. The European Food Safety Authority (EFSA) emphasizes the need for measures to reduce antimicrobial use, including improving farmers’ understanding of herd hygiene and promoting different attitudes towards herd health management in different livestock sectors [17].

4. Materials and Methods

4.1. Sample Collection, Isolation, and Identification of Escherichia coli Isolates

A total of 295 fecal samples were collected from 20 rabbit farms in the Trás-os-Montes, Alto Tâmega, Douro, Ave and Minho regions between October 2022 and February 2023 (Figure 4). At each farm, 15 samples were collected from different locations in the rabbit hutch area to ensure significant samples and to cover the entire rabbit farm.
From each fecal sample, a 5 g aliquot was homogenized and diluted in brain heart infusion (BHI) broth and incubated at 37 °C for 24 h under aerobic conditions. After incubation, samples were plated on Chromocult® Coliform Agar (ChromoCult, Fontenay sous Bois, France) supplemented with 2 µg/mL of cefotaxime. The plates were then incubated at 37 °C for 24 h. One colony per sample with the morphological aspect of E. coli was selected and inoculated onto eosin–methylene blue agar (EMB) and MacConkey agar plates at 37 °C for 24 h. Colonies presumed to have morphological characteristics consistent with E. coli were collected (1 colony per sample) and subjected to standard biochemistry including IMViC reactions (indole, methyl red, Voges–Proskauer, and citric acid). Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS, MALDI Biotyper®, Bruker Daltonik, Bremen, Germany) was used to confirm the species-level identification of bacterial isolates. The isolated E. coli strains were stored at −80 °C for subsequent characterization.

4.2. Antimicrobial Susceptibility Testing

The Kirby–Bauer disk diffusion method was used to assess antibiotic susceptibility on Mueller–Hinton (MH) agar according to the European Committee for Antimicrobial Susceptibility Testing (EUCAST) guidelines (2022) [46]. A total of 16 antibiotics (μg/disc), categorized as human therapeutic (CIA) and critically important veterinary antibiotics (VCIA), were tested for their relevance to human and animal health: ampicillin (10 μg), amoxicillin–clavulanic acid (AMC) (20 + 10 μg), cefoxitin (30 μg), ceftazidime (30 µg), aztreonam (30 µg), imipenem (10 µg), gentamicin (10 µg), amikacin (30 µg), tobramycin (10 µg), streptomycin (10 µg), nalidixic acid (30 µg), ciprofloxacin (5 µg), trimethoprim/sulfamethoxazole (SXT) (1.25/23.75 μg), tetracycline (30 μg), and chloramphenicol (30 μg). Incubation was carried out aerobically at 37 °C for 24 h. The classification of isolates as susceptible or resistant was determined based on the diameter of the zone of inhibition around the antibiotic disk according to the EUCAST breakpoints [46]. One isolate per stool sample was selected for further investigation.

4.3. Characterization of Antimicrobial Resistance Genes and Virulence Genotyping

Genomic DNA from E. coli isolates was extracted using the boiling method, and the presence of antibiotic resistance genes in cefotaxime-resistant isolates was investigated. The presence of b-lactamase genes was analyzed by PCR: blaCTX-M of different groups (groups 3 and 9), blaTEM, blaSHV, and blaOXA. Additionally, PCR was used to identify genes associated with non-beta-lactam resistance, including tetracyclines (tetA, tetM, and tetB), sulfonamides (sul1, sul2 and sul3), streptomycin (strA and strB), chloramphenicol (cmlA), aminoglycosides (ant(2), aph(3), aac(3)-II, aac(3)-IV, aadA1 and aac(6′)-Ib), quinolones (qnrS and qnrA), and colistin (mcr-1). The presence of intI1 and intI2 genes encoding class 1 and 2 integrases was also tested using PCR [47].
PCR assays were used to identify genes associated with virulence factors in E. coli isolates, including fimA (type 1 fimbriae), papGIII (adhesin PapG class III), hlyA (hemolysin), cnf1 (cytotoxic necrotizing factor), papC (P fimbriae), aer (aerobactin iron uptake system), eae (Intimin), and bfp (Type IV bundle forming pili) [47].

4.4. Phylogenetic Diversity and Clonal Relationship

The identification of major phylogenetic groups (A, B1, B2, or D) among the E. coli isolates was established using PCR, incorporating a set of three genes (chuA, yjaA, and TspE4.C2), as outlined by Clermont et al. [48].
The clonal relationship between the different isolates was studied by pulsed-field gel electrophoresis (PFGE) using XbaI enzyme to digest genomic DNA, as previously reported [49]. The PFGE conditions were 6 V cm−2, 14 °C, and pulse time ranging from 1 s to 30 s over the course of 19 h using the CHEF-DR III system (Bio-Rad Laboratories Inc., Hercules, CA, USA). PFGE patterns were analyzed using the Java program GelJ v2 using the Dice coefficient [50]. Isolates with ≥80% of identity were classified as belonging to the same epidemiological clonal group [51]. At least one isolate per PFGE pattern was typed using multilocus sequence typing (MLST) with the Achtman scheme, involving PCR amplification of seven housekeeping genes. Subsequently, all amplicons were sequenced and compared against MLST database sequences to identify specific allele combinations and determine the sequence type (ST) [52].

4.5. Biofilm Formation

The biofilm formation assay was performed according to a previously outlined protocol [23], with some adjustments. Briefly, two fresh colonies from a culture were transferred into tubes containing 3 mL of tryptic soy broth (TSB, Oxoid, Basingstoke, UK) and incubated at 37 °C for 16 ± 1 h with continuous shaking at 120 rpm using a shaker incubator (ES-80 Shaker, Grant Instruments, Cambridge, UK). After this incubation, the bacterial suspension was standardized to an optical density equivalent to 1 × 106 colony-forming units (CFUs), and then 200 μL of each isolate was added to individual wells of a 96-well flat-bottom microplate. E. coli ATTC 25922 served as a positive control and fresh, sterile medium as a negative control. The plates were incubated at 37 °C for 24 h without shaking, with seven technical replicates prepared for each experiment. Biofilm mass was evaluated using the crystal violet (CV) staining method, following the procedure described by Peeters et al. (2008) [53] with some modifications. After incubation, each well was washed twice with 200 μL of distilled water to remove non-adherent bacterial cells. The plates were air-dried at room temperature for approximately 2 h, and then 100 μL of methanol (VWR International, Carnaxide, Portugal) was added to fix the microbial biofilm, then allowed to react for 15 min. Subsequently, methanol was removed, and the plates were air-dried for 10 min at room temperature. Following this, 100 μL of 1% (v/v) CV solution was added to each well and allowed to sit for 10 min. Excess CV solution was removed by washing the plates twice with distilled water. To dissolve CV, 100 μL of 33% (v/v) acetic acid was added, and absorbance was measured at 570 nm using a microplate reader (Bio Tek elX808U, Winooski, VT, USA) [54]. Biofilm formation results for each isolate were presented as a percentage of the results obtained for the reference strain.

5. Conclusions

The emergence of CTX-resistant E. coli recovered from healthy rabbits from 20 different intensive farms across north Portugal highlights a concerning prevalence of antibiotic resistance in rabbit-farming environments and the spread of MDR bacteria. The increase in resistance to antibiotics frequently used in veterinary and human healthcare settings, such as tetracycline, ampicillin, aztreonam, and streptomycin, underscores the growing threat to public health and poses a significant challenge to One Health. The detection of MDR strains on all farms, including the identification of various high-risk and pandemic clones (ST10, ST457, and ST2325), coupled with their great ability to form biofilms, poses a substantial threat to food safety and consumer health and reflects the broad host adaptability and wide geographical spread of these organisms, which suggests the possibility of cross-species transmission and widespread distribution of genes conferring antimicrobial resistance. This study underscores the need for One Health strategies to address antimicrobial resistance in rabbit farming. Regulatory measures and consumer awareness campaigns are crucial for promoting sustainable practices and reducing antibiotic use, and, with these strategies, will ensure long-term sustainability, adaptability, public health, and environmental well-being in rabbit farming.

Author Contributions

Conceptualization, A.S. and V.S.; methodology, A.S., V.S., G.I., M.L., B.R.-B., Y.S. and P.P.; validation, P.P.; formal analysis, A.S., V.S., M.L., B.R.-B. and Y.S.; investigation, A.S., V.S., M.L., B.R.-B. and T.T.; resources, T.T., J.E.P. and A.S.; data curation, P.P., P.V., V.F. and Y.S.; writing—original draft preparation, A.S.; writing—review and editing, A.S. and V.S.; visualization, V.S., P.P., G.I., J.E.P. and A.S.; supervision, P.P., V.F. and P.V. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the projects UIDB/CVT/00772/2020 (Doi: 10.54499/ UIDB/CVT/00772/2020) and LA/P/0059/2020 funded by the Portuguese Foundation for Science and Technology (FCT), and this work received financial support from FCT/MCTES (UIDB/50006/2020 DOI 10.54499/UIDB/50006/2020) through national funds.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

Adriana Silva is grateful to FCT (Fundaҫão para a Ciência e a Tecnologia) for financial support through the PhD grant SFRH/ BD/04576/2020.

Conflicts of Interest

The authors declare no conflicts of interest. Author Teresa Tavares was employed by the company José Azevedo Monteiro, Lda. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Clemente, L.; Leão, C.; Moura, L.; Albuquerque, T.; Amaro, A. Prevalence and Characterization of ESBL/AmpC Producing Escherichia coli from Fresh Meat in Portugal. Antibiotics 2021, 10, 1333. [Google Scholar] [CrossRef]
  2. Homeier-Bachmann, T.; Kleist, J.F.; Schütz, A.K.; Bachmann, L. Distribution of ESBL/AmpC- Escherichia coli on a Dairy Farm. Antibiotics 2022, 11, 940. [Google Scholar] [CrossRef]
  3. Tseng, C.-H.; Liu, C.-W.; Liu, P.-Y. Extended-Spectrum β-Lactamases (ESBL) Producing Bacteria in Animals. Antibiotics 2023, 12, 661. [Google Scholar] [CrossRef] [PubMed]
  4. Ramos, S.; Silva, V.; de Lurdes Enes Dapkevicius, M.; Caniça, M.; Tejedor-Junco, M.T.; Igrejas, G.; Poeta, P. Escherichia coli as Commensal and Pathogenic Bacteria among Food-Producing Animals: Health Implications of Extended Spectrum β-Lactamase (ESBL) Production. Animals 2020, 10, 2239. [Google Scholar] [CrossRef] [PubMed]
  5. Kaesbohrer, A.; Bakran-Lebl, K.; Irrgang, A.; Fischer, J.; Kämpf, P.; Schiffmann, A.; Werckenthin, C.; Busch, M.; Kreienbrock, L.; Hille, K. Diversity in Prevalence and Characteristics of ESBL/PAmpC Producing E. Coli in Food in Germany. Vet. Microbiol. 2019, 233, 52–60. [Google Scholar] [CrossRef] [PubMed]
  6. Widodo, A.; Effendi, M.H.; Khairullah, A.R. Extended-Spectrum Beta -Lactamase (ESBL)-Producing Escherichia coli from Livestock. Syst. Rev. Pharm. 2020, 11, 382–392. [Google Scholar]
  7. Silva, A.; Silva, V.; Pereira, J.E.; Maltez, L.; Igrejas, G.; Valentão, P.; Falco, V.; Poeta, P. Antimicrobial Resistance and Clonal Lineages of Escherichia coli from Food-Producing Animals. Antibiotics 2023, 12, 1061. [Google Scholar] [CrossRef]
  8. Suay-García, B.; Galán, F.; Rodríguez-Iglesias, M.A.; Pérez-Gracia, M.T. Detection and Characterization of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli in Animals. Vector-Borne Zoonotic Dis. 2019, 19, 115–120. [Google Scholar] [CrossRef] [PubMed]
  9. Crovato, S.; Menegon, F.; Mascarello, G.; Pinto, A.; Nadin, A.; Piovan, G.; Ricaldi, G.; Di Martino, G.; Pozza, G. Development of a Training Strategy Aimed at Increasing Veterinarians’ Awareness of the Proper Use of Antibiotics on Rabbit Farms. Animals 2023, 13, 2411. [Google Scholar] [CrossRef]
  10. Saxmose Nielsen, S.; Alvarez, J.; Bicout, D.J.; Calistri, P.; Depner, K.; Drewe, J.A.; Garin-Bastuji, B.; Gonzales Rojas, J.L.; Gortázar Schmidt, C.; Michel, V.; et al. Health and Welfare of Rabbits Farmed in Different Production Systems. EFSA J. 2020, 18, e05944. [Google Scholar] [CrossRef]
  11. Nielsen, S.S.; Bicout, D.J.; Calistri, P.; Canali, E.; Drewe, J.A.; Garin-Bastuji, B.; Gonzales Rojas, J.L.; Gortazar Schmidt, C.; Herskin, M.; Michel, V.; et al. Assessment of Animal Diseases Caused by Bacteria Resistant to Antimicrobials: Rabbits. EFSA J. 2021, 19, e06999. [Google Scholar] [CrossRef]
  12. Ben Rhouma, R.; Jouini, A.; Klibi, A.; Hamrouni, S.; Boubaker, A.; Kmiha, S.; Maaroufi, A. Molecular Characterisation of Antimicrobial Resistance and Virulence Genes in Escherichia coli Strains Isolated from Diarrhoeic and Healthy Rabbits in Tunisia. World Rabbit Sci. 2020, 28, 81–91. [Google Scholar] [CrossRef]
  13. Massella, E.; Giacometti, F.; Bonilauri, P.; Reid, C.J.; Djordjevic, S.P.; Merialdi, G.; Bacci, C.; Fiorentini, L.; Massi, P.; Bardasi, L.; et al. Antimicrobial Resistance Profile and Expec Virulence Potential in Commensal Escherichia coli of Multiple Sources. Antibiotics 2021, 10, 351. [Google Scholar] [CrossRef] [PubMed]
  14. Zhao, X.; Yang, J.; Ju, Z.; Chang, W.; Sun, S. Molecular Characterization of Antimicrobial Resistance in Escherichia coli from Rabbit Farms in Tai’an, China. BioMed Res. Int. 2018, 2018, 8607647. [Google Scholar] [CrossRef] [PubMed]
  15. Attili, A.R.; Bellato, A.; Robino, P.; Galosi, L.; Papeschi, C.; Rossi, G.; Fileni, E.; Linardi, M.; Cuteri, V.; Chiesa, F.; et al. Analysis of the Antibiotic Resistance Profiles in Methicillin-Sensitive S. aureus Pathotypes Isolated on a Commercial Rabbit Farm in Italy. Antibiotics 2020, 9, 673. [Google Scholar] [CrossRef] [PubMed]
  16. Agnoletti, F.; Brunetta, R.; Bano, L.; Drigo, I.; Mazzolini, E. Longitudinal Study on Antimicrobial Consumption and Resistance in Rabbit Farming. Int. J. Antimicrob. Agents 2018, 51, 197–205. [Google Scholar] [CrossRef]
  17. Di Martino, G.; Crovato, S.; Pinto, A.; Dorotea, T.; Mascarello, G.; Brunetta, R.; Agnoletti, F.; Bonfanti, L. Farmers’ Attitudes towards Antimicrobial Use and Awareness of Antimicrobial Resistance: A Comparative Study among Turkey and Rabbit Farmers. Ital. J. Anim. Sci. 2019, 18, 194–201. [Google Scholar] [CrossRef]
  18. Food, E.; Authority, S. The European Union Summary Report on Antimicrobial Resistance in Zoonotic and Indicator Bacteria from Humans, Animals and Food in 2017/2018. EFSA J. 2020, 18, e07867. [Google Scholar] [CrossRef]
  19. Sousa, M.; Silva, V.; Silva, A.; Silva, N.; Ribeiro, J.; Tejedor-Junco, M.T.; Capita, R.; Chenouf, N.S.; Alonso-Calleja, C.; Rodrigues, T.M.; et al. Staphylococci among Wild European Rabbits from the Azores: A Potential Zoonotic Issue? J. Food Prot. 2020, 83, 1110–1114. [Google Scholar] [CrossRef]
  20. Jenckel, M.; Hall, R.N.; Strive, T. Pathogen Profiling of Australian Rabbits by Metatranscriptomic Sequencing. Transbound. Emerg. Dis. 2022, 69, e2629–e2640. [Google Scholar] [CrossRef]
  21. Kylie, J.; Brash, M.; Whiteman, A.; Tapscott, B.; Slavic, D.; Weese, J.S.; Turner, P.V. Biosecurity Practices and Causes of Enteritis on Ontario Meat Rabbit Farms. Can. Vet. J. 2017, 58, 571–578. [Google Scholar] [PubMed]
  22. Vaz-Moreira, I.; Ferreira, C.; Nunes, O.C.; Manaia, C.M. Part III: Socio-Economical Perspectives and Impact of AR. In Sources of Antibiotic Resistance: Zoonotic, Human, Environment; Wiley: Hoboken, NJ, USA, 2020; pp. 211–238. [Google Scholar]
  23. Qian, J.; Wu, Z.; Zhu, Y.; Liu, C. One Health: A Holistic Approach for Food Safety in Livestock. Sci. One Health 2022, 1, 100015. [Google Scholar] [CrossRef]
  24. Scott, H.M.; Acuff, G.; Bergeron, G.; Bourassa, M.W.; Gill, J.; Graham, D.W.; Kahn, L.H.; Morley, P.S.; Salois, M.J.; Simjee, S.; et al. Critically Important Antibiotics: Criteria and Approaches for Measuring and Reducing Their Use in Food Animal Agriculture. Ann. N. Y. Acad. Sci. 2019, 1441, 8–16. [Google Scholar] [CrossRef] [PubMed]
  25. Bessalah, S.; Fairbrother, J.M.; Salhi, I.; Vanier, G.; Khorchani, T.; Seddik, M.M.; Hammadi, M. Characterization and Antimicrobial Susceptibility of Escherichia coli Isolated from Healthy Farm Animals in Tunisia. Anim. Biotechnol. 2021, 32, 748–757. [Google Scholar] [CrossRef] [PubMed]
  26. Silva, N.; Igrejas, G.; Figueiredo, N.; Gonçalves, A.; Radhouani, H.; Rodrigues, J.; Poeta, P. Molecular Characterization of Antimicrobial Resistance in Enterococci and Escherichia coli Isolates from European Wild Rabbit (Oryctolagus cuniculus). Sci. Total Environ. 2010, 408, 4871–4876. [Google Scholar] [CrossRef] [PubMed]
  27. Marinho, C.; Igrejas, G.; Gonçalves, A.; Silva, N.; Santos, T.; Monteiro, R.; Gonçalves, D.; Rodrigues, T.; Poeta, P. Azorean Wild Rabbits as Reservoirs of Antimicrobial Resistant Escherichia coli. Anaerobe 2014, 30, 116–119. [Google Scholar] [CrossRef] [PubMed]
  28. Cummins, E.A.; Snaith, A.E.; McNally, A.; Hall, R.J. The Role of Potentiating Mutations in the Evolution of Pandemic Escherichia coli Clones. Eur. J. Clin. Microbiol. Infect. Dis. 2021, 1–10. [Google Scholar] [CrossRef] [PubMed]
  29. Freitas-Silva, J.; Inácio, Â.S.; Mourão, J.; Antunes, P.; Mendes, Â.; de Carvalho, A.P.; Vasconcelos, V.; Peixe, L.; da Costa, P.M. Occurrence of Mcr-1 in Escherichia coli from Rabbits of Intensive Farming. Vet. Microbiol. 2018, 227, 78–81. [Google Scholar] [CrossRef]
  30. Fuga, B.; Sellera, F.P.; Cerdeira, L.; Esposito, F.; Cardoso, B.; Fontana, H.; Moura, Q.; Cardenas-Arias, A.; Sano, E.; Ribas, R.M.; et al. WHO Critical Priority Escherichia coli as One Health Challenge for a Post-Pandemic Scenario: Genomic Surveillance and Analysis of Current Trends in Brazil. Microbiol. Spectr. 2022, 10, e0125621. [Google Scholar] [CrossRef]
  31. Nobili, G.; Franconieri, I.; Basanisi, M.G.; La Bella, G.; Tozzoli, R.; Caprioli, A.; La Salandra, G. Short Communication: Isolation of Shiga Toxin-Producing Escherichia coli in Raw Milk and Mozzarella Cheese in Southern Italy. J. Dairy Sci. 2016, 99, 7877–7880. [Google Scholar] [CrossRef]
  32. Zając, M.; Sztromwasser, P.; Bortolaia, V.; Leekitcharoenphon, P.; Cavaco, L.M.; Ziȩtek-Barszcz, A.; Hendriksen, R.S.; Wasyl, D. Occurrence and Characterization of Mcr-1-Positive Escherichia coli Isolated From Food-Producing Animals in Poland, 2011–2016. Front. Microbiol. 2019, 10, 1753. [Google Scholar] [CrossRef] [PubMed]
  33. Bai, X.; Hu, B.; Xu, Y.; Sun, H.; Zhao, A.; Ba, P.; Fu, S.; Fan, R.; Jin, Y.; Wang, H.; et al. Molecular and Phylogenetic Characterization of Non-O157 Shiga Toxin-Producing Escherichia coli Strains in China. Front. Cell. Infect. Microbiol. 2016, 6, 143. [Google Scholar] [CrossRef]
  34. Vignaroli, C.; Luna, G.M.; Rinaldi, C.; Di Cesare, A.; Danovaro, R.; Biavasco, F. New Sequence Types and Multidrug Resistance among Pathogenic Escherichia coli Isolates from Coastal Marine Sediments. Appl. Environ. Microbiol. 2012, 78, 3916–3922. [Google Scholar] [CrossRef]
  35. Nesporova, K.; Wyrsch, E.R.; Valcek, A.; Bitar, I.; Chaw, K.; Harris, P.; Hrabak, J.; Literak, I.; Djordjevic, S.P.; Dolejskaa, M. Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals. Antimicrob. Agents Chemother. 2021, 65, e01118-20. [Google Scholar] [CrossRef] [PubMed]
  36. Sano, E.; Esposito, F.; Fontana, H.; Fuga, B.; Cardenas-Arias, A.; Moura, Q.; Cardoso, B.; Costa, G.C.V.; Bosqueiro, T.C.M.; Sinhorini, J.A.; et al. One Health Clones of Multidrug-Resistant Escherichia coli Carried by Synanthropic Animals in Brazil. One Health 2023, 16, 100476. [Google Scholar] [CrossRef] [PubMed]
  37. Carvalho, I.; Tejedor-Junco, M.T.; González-Martín, M.; Corbera, J.A.; Suárez-Pérez, A.; Silva, V.; Igrejas, G.; Torres, C.; Poeta, P. Molecular Diversity of Extended-Spectrum β-Lactamase-Producing Escherichia coli from Vultures in Canary Islands. Environ. Microbiol. Rep. 2020, 12, 540–547. [Google Scholar] [CrossRef]
  38. Yu, Y.; Cui, C.Y.; Kuang, X.; Chen, C.; Wang, M.G.; Liao, X.P.; Sun, J.; Liu, Y.H. Prevalence of Tet(X4) in Escherichia coli From Duck Farms in Southeast China. Front. Microbiol. 2021, 12, 716393. [Google Scholar] [CrossRef]
  39. Sun, L.; Meng, N.; Wang, Z.; Hong, J.; Jiao, X.; Dai, Y.; Wang, Z.; Wang, J. Genomic Characterization of ESBL/AmpC-Producing Escherichia coli in Stray Dogs Sheltered in Yangzhou, China. Infect. Drug Resist. 2022, 15, 7741–7750. [Google Scholar] [CrossRef] [PubMed]
  40. Juraschek, K.; Deneke, C.; Schmoger, S.; Grobbel, M.; Malorny, B.; Käsbohrer, A.; Schwarz, S.; Meemken, D.; Hammerl, J.A. Phenotypic and Genotypic Properties of Fluoroquinolone-Resistant, Qnr-Carrying Escherichia coli Isolated from the German Food Chain in 2017. Microorganisms 2021, 9, 1308. [Google Scholar] [CrossRef]
  41. Zhou, F.; Wang, D.; Hu, J.; Zhang, Y.; Tan, B.K.; Lin, S. Control Measurements of Escherichia coli Biofilm: A Review. Foods 2022, 11, 2469. [Google Scholar] [CrossRef]
  42. Barilli, E.; Vismarra, A.; Frascolla, V.; Rega, M.; Bacci, C. Escherichia coli Strains Isolated from Retail Meat Products: Evaluation of Biofilm Formation Ability, Antibiotic Resistance, and Phylogenetic Group Analysis. J. Food Prot. 2020, 83, 233–240. [Google Scholar] [CrossRef]
  43. Sivaranjani, M.; McCarthy, M.C.; Sniatynski, M.K.; Wu, L.; Dillon, J.A.R.; Rubin, J.E.; White, A.P. Biofilm Formation and Antimicrobial Susceptibility of Escherichia coli Associated with Colibacillosis Outbreaks in Broiler Chickens From Saskatchewan. Front. Microbiol. 2022, 13, 841516. [Google Scholar] [CrossRef]
  44. Kaleva, M.D.; Ilieva, Y.; Zaharieva, M.M.; Dimitrova, L.; Kim, T.C.; Tsvetkova, I.; Georgiev, Y.; Orozova, P.; Nedev, K.; Najdenski, H. Antimicrobial Resistance and Biofilm Formation of Escherichia coli Isolated from Pig Farms and Surroundings in Bulgaria. Microorganisms 2023, 11, 1909. [Google Scholar] [CrossRef]
  45. Ray, R.; Singh, P. Prevalence and Implications of Shiga Toxin-Producing Escherichia coli in Farm and Wild Ruminants. Pathogens 2022, 11, 1332. [Google Scholar] [CrossRef]
  46. EUCAST Breakpoint Tables for Interpretation of MICs and Zone Diameters 2022. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, version 10.0. 2020. Available online: http://www.eucast.org (accessed on 3 February 2024).
  47. Carvalho, I.; Cunha, R.; Martins, C.; Martínez-Álvarez, S.; Chenouf, N.S.; Pimenta, P.; Pereira, A.R.; Ramos, S.; Sadi, M.; Martins, Â.; et al. Antimicrobial Resistance Genes and Diversity of Clones among Faecal ESBL-Producing Escherichia coli Isolated from Healthy and Sick Dogs Living in Portugal. Antibiotics 2021, 10, 1013. [Google Scholar] [CrossRef]
  48. Clermont, O.; Bonacorsi, S.; Bingen, E. Rapid and Simple Determination of the Escherichia coli Phylogenetic Group. Appl. Environ. Microbiol. 2000, 66, 4555–4558. [Google Scholar] [CrossRef] [PubMed]
  49. Gautom, R.K. Rapid Pulsed-Field Gel Electrophoresis Protocol for Typing of Escherichia coli O157:H7 and Other Gram-Negative Organisms in 1 Day. J. Clin. Microbiol. 1997, 35, 2977–2980. [Google Scholar] [CrossRef] [PubMed]
  50. Heras, J.; Domínguez, C.; Mata, E.; Pascual, V.; Lozano, C.; Torres, C.; Zarazaga, M. GelJ—A Tool for Analyzing DNA Fingerprint Gel Images. BMC Bioinform. 2015, 16, 270. [Google Scholar] [CrossRef] [PubMed]
  51. Guiral, E.; Pons, M.J.; Vubil, D.; Marí-Almirall, M.; Sigaúque, B.; Soto, S.M.; Alonso, P.L.; Ruiz, J.; Vila, J.; Mandomando, I. Epidemiology and Molecular Characterization of Multidrug-Resistant Escherichia coli Isolates Harboring BlaCTX-M Group 1 Extended-Spectrum β-Lactamases Causing Bacteremia and Urinary Tract Infection in Manhiça, Mozambique. Infect. Drug Resist. 2018, 11, 927–936. [Google Scholar] [CrossRef]
  52. Wirth, T.; Falush, D.; Lan, R.; Colles, F.; Mensa, P.; Wieler, L.H.; Karch, H.; Reeves, P.R.; Maiden, M.C.J.; Ochman, H.; et al. Sex and Virulence in Escherichia coli: An Evolutionary Perspective. Mol. Microbiol. 2006, 60, 1136–1151. [Google Scholar] [CrossRef]
  53. Peeters, E.; Nelis, H.J.; Coenye, T. Comparison of Multiple Methods for Quantification of Microbial Biofilms Grown in Microtiter Plates. J. Microbiol. Methods 2008, 72, 157–165. [Google Scholar] [CrossRef] [PubMed]
  54. Silva, V.; Correia, E.; Pereira, J.E.; González-Machado, C.; Capita, R.; Alonso-Calleja, C.; Igrejas, G.; Poeta, P. Biofilm Formation of Staphylococcus aureus from Pets, Live-Stock, and Wild Animals: Relationship with Clonal Lineages and Antimicrobial Resistance. Antibiotics 2022, 11, 772. [Google Scholar] [CrossRef] [PubMed]
Antibiotics 13 00376 g001
Figure 1. Heatmap showing the multiple resistance profiles of CTX-resistant E. coli isolates isolated from rabbit farms. The resistance to six different classes of antibiotics and seven different classes of antibiotics had highest association with the number of isolates in comparison to resistant to three, four and five different classes of antibiotics. The grading numbers in color strip depicts the number of different classes of antibiotics. The copy number, ranging from 0 to 27, was indicated by yellow to red.
Figure 1. Heatmap showing the multiple resistance profiles of CTX-resistant E. coli isolates isolated from rabbit farms. The resistance to six different classes of antibiotics and seven different classes of antibiotics had highest association with the number of isolates in comparison to resistant to three, four and five different classes of antibiotics. The grading numbers in color strip depicts the number of different classes of antibiotics. The copy number, ranging from 0 to 27, was indicated by yellow to red.
Antibiotics 13 00376 g001
Antibiotics 13 00376 g002
Figure 2. PFGE dendrogram of CTX-resistant E. coli strains from different rabbit farms in the north of Portugal. Braces indicate classification in the corresponding PFGE cluster or pulsotype. Isolates were included in the same pulsotype if their similarity indices were ≥80%. The strains selected to perform the MLST are highlighted in red.
Figure 2. PFGE dendrogram of CTX-resistant E. coli strains from different rabbit farms in the north of Portugal. Braces indicate classification in the corresponding PFGE cluster or pulsotype. Isolates were included in the same pulsotype if their similarity indices were ≥80%. The strains selected to perform the MLST are highlighted in red.
Antibiotics 13 00376 g002
Antibiotics 13 00376 g003
Figure 3. % Biofilm formation capacity (expressed as % in comparison to reference strain) of E. coli strains isolated from different rabbit farms. The strains were divided according to their resistance phenotypes. The symbols represent the biomass mean of the biofilm formed in independent tests of the individual isolates. The red lines represent the mean biofilm mass formed per group. Statistical significance was determined using Tukey’s multiple comparisons test (* p < 0.05; *** p < 0.001).
Figure 3. % Biofilm formation capacity (expressed as % in comparison to reference strain) of E. coli strains isolated from different rabbit farms. The strains were divided according to their resistance phenotypes. The symbols represent the biomass mean of the biofilm formed in independent tests of the individual isolates. The red lines represent the mean biofilm mass formed per group. Statistical significance was determined using Tukey’s multiple comparisons test (* p < 0.05; *** p < 0.001).
Antibiotics 13 00376 g003
Antibiotics 13 00376 g004
Figure 4. Geographic locations of rabbit farms. Samples were collected from 20 rabbit farms in the Trás-os-Montes, Alto Tâmega, Douro, Ave, and Minho regions. Each farm is marked in a different color.
Figure 4. Geographic locations of rabbit farms. Samples were collected from 20 rabbit farms in the Trás-os-Montes, Alto Tâmega, Douro, Ave, and Minho regions. Each farm is marked in a different color.
Antibiotics 13 00376 g004
Table 1. Phenotypic and genotypic characterization of CTX-resistant E. coli isolates that were not chosen for MLST analysis.
Table 1. Phenotypic and genotypic characterization of CTX-resistant E. coli isolates that were not chosen for MLST analysis.
IsolateFarmResistance PhenotypeResistance GenotypePhylogenetic GroupIntegrase GeneVirulence GenesPFGE Pattern
ASC43AMP-S-TOB-CTX-NA-CIP-SXT-C-TEsul1-sul3-qnrS- -strA-strB- blaCTX-3G-tetB-aac(6)-IbAint1fimA-bfpP9
ASC63ATM-AMP-S-TOB-CTX-NA-CIP-SXT-C-TEsul1-sul3-tetA-qnrS-qnrA-—strA-strB- blaCTX-3G-tetB-aac(6)-Ib-blaTEMAint1papG-III-fimAP9
ASC73ATM-AMP-AK-CN-S-TOB-CTX-NA-CIP-SXT-C-TEsul1-sul3-tetA-tetB-qnrS-qnrA- -aac(3)-IV-aac(3)-II- strA- blaCTX-3G- aac(6)-Ib-blaTEMAint1papG-III-fimA-bfpP9
ASC83AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul1-sul3-tetA -strA- strB-blaCTX-3GB1int1fimAP4
ASC114AUG-ATM-AMP-S-CTX-CAZ-SXT-C-TEsul2-sul3-tetA- strA-strB- blaCTX-3G-blaTEMAint1papG-III-fimA-bfpP8
ASC124AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul2-sul3-tetA-strA-strB- blaCTX-3G-blaTEMAint1papG-III-fimA-bfpP8
ASC134AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul2-sul3-tetA- strA-strB- blaCTX-3G-blaTEMAint1papG-III-fimA-bfpP8
ASC144AUG-ATM-AMP-S-CTX-SXT-C-TEsul2-sul3-tetA- strA-strB- blaCTX-3G-blaTEMAint1papG-III-fimA-bfpP8
ASC154AUG-ATM-AMP-S-CTX-SXT-C-TEsul1-sul2-sul3-tetA- tetB- strA-strB- blaCTX-3G- blaTEMAint1papG-III-fimA-bfpP8
ASC164AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul1-sul3-tetA-cmlA -strA-strB- blaCTX-3G-blaCTX-M9-blaTEMAint1papG-III-fimA-bfpP8
ASC174AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul3-tetA-cmlA- strA-strB-blaCTX-3G-blaCTX-M9-aadA5-blaTEMAint1papG-III-fimA-bfpP8
ASC195AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul1-sul3-tetA-cmlA- strA-strB- blaCTX-M9B1int1papG-III-fimAP3
ASC205AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul3-cmlA- strA-strB-blaCTX-3G-blaCTX-M9-aadA5-blaTEMB1int1papG-IIIP2
ASC225AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul3-cmlA -strA-strB-blaCTX-M9-blaTEMB1int1papG-IIIP2
ASC235AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul2-sul3-cmlA-strA- blaCTX-M9-aadA5-blaTEMB1-papG-IIIP3
ASC255AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul2-sul3-tetA-cmlA-blaCTXM-strA-strB- blaTEMB1int1papG-IIIP3
ASC265AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul1-sul2-sul3-cmlA- strA-strB- blaCTX-M9-blaTEMB1int1papG-IIIP2
ASC275AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul1-sul2-sul3-tetA-cmlA- strA-strB- blaCTX-M9-blaTEMB1int1papG-IIIP2
ASC285AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul1-sul3-tetA-cmlA-strA-strB- blaCTX-M9-blaTEMB1int1papG-IIIP2
ASC326ATM-AMP-S-TOB-CTX-CAZsul3- strA-strB-blaCTX-3G-blaCTX-M9B1-papG-IIIP5
ASC336ATM-AMP-S-TOB-CTX-SXT-CAZsul3-strA- blaCTX-3G-aadA5-blaTEMB1--P5
ASC3513ATM-AMP-S-CTX-NA-CIP-SXT-C-TEqnrS-qnrA-parC-cmlA-tetA- blaCTX-3G-blaCTX-M9-aac(6)-Ib-aadA5-blaSHVDint1papG-IIIP1
ASC3813ATM-AMP-S-CTX-C-TEcmlA-tetA- tetB-blaCTX-M9-blaTEM-blaSHVA-papG-III-bfpP7
ASC4113ATM-AMP-S-CTX-NA-CIP-SXT-TEqnrS-qnrA-tetA- blaCTX-M9 blaCTX-3G-aac(6)-Ib-blaTEMAint1papG-III-fimAP6
ASC4213ATM-AMP-S-CTX-NA-CIP-SXT-TEqnrA -tetA- tetB-blaCTX-M9 blaCTX-3G-aac(6)-Ib-blaTEMAint1papG-III-fimA-bfpP7
ASC4313ATM-AMP-S-CTX-NA-CIP-SXT-TEqnrS-qnrA- tetA-tetB blaCTX-3G-aac(6)-Ib-aadA5Aint1papG-III-fimAP6
ASC4413ATM-AMP-CTX-TEtetB-blaCTX-M9-blaCTX-3GA-papG-III-fimA-bfpP7
ASC4513ATM-AMP-CTX-TEtetB-blaCTX-M9-blaCTX-3G-blaTEMA-papG-III-fimA-bfpP7
ASC4713ATM-AMP-S-TOB-CTX-TEtetB-blaCTX-M9-blaCTX-3GA-papG-III-fimA-bfpP7
Legend: PFGE—Pulsed-field gel electrophoresis; AUG—amoxicillin–clavulanic acid; ATM—aztreonam; AMP—ampicillin; AK—amikacin; CN—gentamicin; S—streptomycin; TOB—tobramycin; CTX—cefotaxime; CAZ—ceftazidime; NA—nalidixic acid; CIP—ciprofloxacin; SXT—trimethoprim-sulfamethoxazole; C—chloramphenicol; TE—tetracycline.
Table 2. Characterization of 19 CTX-resistant E. coli isolates that were chosen by PFGE for the analysis of clonal lineages by MLST.
Table 2. Characterization of 19 CTX-resistant E. coli isolates that were chosen by PFGE for the analysis of clonal lineages by MLST.
IsolateFarmMLSTResistance PhenotypeResistance GenotypePhylogenetic GroupIntegrase GeneVirulence GenesPFGE Pattern
ASC12ST10AUG-ATM-AMP-S-TOB-CTX-CAZ-NA-CIP-SXT-C-TEsul2-sul3-tetA-cmlA -strA-strB- blaCTX-3G-tetB-aac(6)-IbAintI1fimA-bfpP10
ASC23ST1611AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul1-sul3-tetA -strA-strB- blaCTX-3GB1intI1papG-III-fimAP4
ASC33ST8470AUG-ATM-AMP-S-TOB-CTX-NA-CIP-SXT-C-TEsul1-sul3-tetA-qnrS-qnrA-strA-strB- blaCTX-3G-aac(6)-Ib-blaTEMAint1papG-III-fimA-bfpP9
ASC53ST1611AUG-ATM-AMP-CN-S-TOB-CTX-SXT-C-TEsul1-sul3-tetA-aac(3)-IV-aac(3)-II- strA-strB- blaCTX-3GB1-papG-I-fimA IIP4
ASC93ST8470AUG-ATM-AMP-S-TOB-CTX-NA-CIP-SXT-C-TEsul1-sul3-tetA-qnrS-qnrA- strA-strB- blaCTX-3G-tetB-blaTEMA-fimA-cnf1P9
ASC104ST10AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul1-sul2-sul3-tetA- strA-strB- blaCTX-3G-blaTEMAint1papG-III-fimA-bfpP8
ASC185ST2825AUG-ATM-AMP-AK-CN-S-TOB-CTX-SXT-C-TEsul1-sul2-aac(3)-IV-aac(3)-II-cmlA-strA-strB- blaCTX-3G-blaCTX-M9B1int1papG-III-fimAP2
ASC215ST2825AUG-ATM-AMP-S-TOB-CTX-SXT-C-TEsul2-cmlA-strA-strB- blaCTX-M9-blaTEMB1int1papG-III-fimAP3
ASC245ST2825AUG-ATM-AMP-CN-S-TOB-CTX-SXT-C-TEsul2-sul3-tetA-aac(3)-IV-aac(3)-II-cmlA- strA-strB-blaCTX-3G-blaCTX-M9-aadA5-blaTEMB1int1papG-IIIP3
ASC295ST2825AUG-ATM-AMP-AK-CN-S-TOB-CTX-SXT-C-TEsul1-sul3-tetA-aac(3)-IV-aac(3)-II-cmlA strA-strB-blaCTX-M9-blaTEMB1int1papG-IIIP3
ASC306ST8823ATM-AMP-S-TOB-CTX-CAZsul3-strB-blaCTX-3G-blaCTX-M9B1--P5
ASC316ST8823ATM-AMP-S-TOB-CTX-CAZsul3- strA-strB-blaCTX-3GB1-papG-IIIP5
ASC3413ST457ATM-AMP-S-CTX-NA-CIP-SXT-C-TEtetA-qnrA -qnrS-cmlA- blaCTX-3G-aac(6)-Ib-aadA5-blaTEMDint1papG-III-bfpP1
ASC3613ST2325ATM-AMP-CTX-TEtetB-blaCTX-3G- blaCTX-M9-blaTEMA-papG-III-bfpP7
ASC3713ST2325ATM-AMP-S-CTX-CAZ-NA-CIP-SXT-TEtetA-qnrS-qnrA-blaCTX-M9-blaSHVAint1papG-IIIP6
ASC3913ST2325ATM-AMP-S-CTX-TEtetB-blaCTX-M9-aadA5A-papG-III-bfpP6
ASC4013ST2325ATM-AMP-S-CTX-C-TEcmlA-tetA-tetB-blaCTX-M9-blaCTX-3G-aadA5A-papG-III-bfpP6
ASC4613ST2325ATM-AMP-S-TOB-CTX-C-TEcmlA-tetA- tetB-blaCTX-M9A-papG-III-fimA-bfpP6
ASC4813ST2325ATM-AMP-S-CTX-C-TEcmlA-tetA- blaCTX-M9-blaCTX-3G-blaTEM- blaSHVA-papG-III-fimA-bfpP7
Legend: MLST—Multilocus sequence typing; PFGE—pulsed-field gel electrophoresis; AUG—amoxicillin–clavulanic acid; ATM—aztreonam; AMP—ampicillin; AK—amikacin; CN—gentamicin; S—streptomycin; TOB—tobramycin; CTX—cefotaxime; CAZ—ceftazidime; NA—nalidixic acid; CIP—ciprofloxacin; SXT—trimethoprim-sulfamethoxazole; C—chloramphenicol; TE—tetracycline.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Silva, A.; Silva, V.; Tavares, T.; López, M.; Rojo-Bezares, B.; Pereira, J.E.; Falco, V.; Valentão, P.; Igrejas, G.; Sáenz, Y.; et al. Rabbits as a Reservoir of Multidrug-Resistant Escherichia coli: Clonal Lineages and Public Health Impact. Antibiotics 2024, 13, 376. https://doi.org/10.3390/antibiotics13040376

AMA Style

Silva A, Silva V, Tavares T, López M, Rojo-Bezares B, Pereira JE, Falco V, Valentão P, Igrejas G, Sáenz Y, et al. Rabbits as a Reservoir of Multidrug-Resistant Escherichia coli: Clonal Lineages and Public Health Impact. Antibiotics. 2024; 13(4):376. https://doi.org/10.3390/antibiotics13040376

Chicago/Turabian Style

Silva, Adriana, Vanessa Silva, Teresa Tavares, María López, Beatriz Rojo-Bezares, José Eduardo Pereira, Virgílio Falco, Patrícia Valentão, Gilberto Igrejas, Yolanda Sáenz, and et al. 2024. "Rabbits as a Reservoir of Multidrug-Resistant Escherichia coli: Clonal Lineages and Public Health Impact" Antibiotics 13, no. 4: 376. https://doi.org/10.3390/antibiotics13040376

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop